Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 12Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Lung Neoplasms 3Peripheral Nervous System Diseases 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Multiple Myeloma 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Infections 1

Interventions

Dexamethasone 809Bortezomib 449Lenalidomide 430Cyclophosphamide 336Melphalan 251Calcium Dobesilate 237daratumumab 218pomalidomide 202carfilzomib 181fludarabine phosphate 131Thalidomide 121fludarabine 118Peripheral Blood Stem Cell Transplantation 117Filgrastim 111ixazomib 85Mycophenolic Acid 85Granulocyte Colony-Stimulating Factor 84Busulfan 83Whole-Body Irradiation 80Tacrolimus 75dexamethasone acetate 74Cyclosporine 67isatuximab 64Prednisone 64dexamethasone 21-phosphate 63elotuzumab 60auricularum 57belantamab mafodotin 55Antilymphocyte Serum 55Etoposide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Fish Oils × Clear all
NCT07403071 2026-02-11

Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting
200 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡